Global Antimicrobial Resistance
Antimicrobial-resistant pathogens arise from the overuse of antimicrobials in humans, agriculture, and the environment, rendering many existing antimicrobial treatments ineffective. The number of annual deaths due to resistant infections will continue to increase, as will the economic and social impacts of drug resistance. Coordinated global action is needed to successfully address the threat of antimicrobial resistance, through new innovation, collaboration, and attention among global health actors and the public.
We are working to bring the science of global strategy to bear on how to achieve the necessary level of global action.
Featured Work
WHO Collaborating Centre on Global Governance of Antimicrobial Resistance
The International Network for AMR Social Science (INAMRSS)
SAFE AMR Governance Partnership
People block – please see right sidebar for options.
Susan Rogers Van Katwyk
Managing Director, AMR Policy Accelerator
Daniela Corno
Project Coordinator
Isaac Weldon
Investigator